SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-22-010984
Filing Date
2022-06-01
Accepted
2022-06-01 09:00:29
Documents
95
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A grna-20220331.htm   iXBRL 10-Q/A 2795666
2 EX-31.1 grna-ex31_1.htm EX-31.1 29374
3 EX-31.2 grna-ex31_2.htm EX-31.2 29216
4 EX-32.1 grna-ex32_1.htm EX-32.1 31122
  Complete submission text file 0000950170-22-010984.txt   13165063

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20220331_def.xml EX-101.DEF 537781
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20220331.xsd EX-101.SCH 97317
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grna-20220331_cal.xml EX-101.CAL 64511
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20220331_pre.xml EX-101.PRE 629266
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20220331_lab.xml EX-101.LAB 647159
89 EXTRACTED XBRL INSTANCE DOCUMENT grna-20220331_htm.xml XML 2728139
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39894 | Film No.: 22986088
SIC: 2836 Biological Products, (No Diagnostic Substances)